Effect of persistent use of antihypertensives on blood pressure goal attainment

Current Medical Research and Opinion

Volumn 24, Issue 4, 2008, Pages 1025-1031

  Breekveldt Postma, Nancy S ^a   Penningvan Beest, Fernie J A ^a   Siiskonen, Satu J ^b   Koerselman, Jeroen ^a   Klungel, Olaf H ^c   Falvey, Heather ^d   Vincze, Gábor ^d   Herings, Ron M C ^a,b  

^a PHARMO INSTITUTE FOR DRUG OUTCOMES RESEARCH   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Antihypertensives; Blood pressure goal attainment; Hypertension; Persistence

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CLINICAL PRACTICE; COHORT ANALYSIS; CONFIDENCE INTERVAL; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FEMALE; GOAL ATTAINMENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MEDICAL RECORD; NETHERLANDS; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DATABASES AS TOPIC; DRUG UTILIZATION; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; NETHERLANDS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 42549150341     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079908X280554     Document Type: Article

References (22)

1. Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta- analysis. JAMA 2003;289:2534-44
2. Bonow RO, Smaha LA, Smith SC, Jr, et al. World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation 2002;106:1602-5
3. Wolf HK, Tuomilehto J, Kuulasmaa K, et al. Blood pressure levels in the 41 populations of the WHO MONICA Project. J Hum Hypertens 1997;11:733-42
4. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349:1436-42
5. Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med 2007;167:141-7
6. Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of tenyear risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003
7. Neutel JM, Smith DH. Improving patient compliance: a major goal in the management of hypertension. J Clin Hypertens (Greenwich) 2003;5:127-32
8. Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Eng J Med 1998;339:1957-63
9. Erkens JA, Panneman MM, Klungel OH, et al. Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study. Pharmacoepidemiol Drug Saf 2005;14:795-803
10. Degli Esposti L, Degli Esposti E, Valpiani G, et al. A retrospective, population- based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy. Clin Ther 2002;24:1347-57; discussion 6
11. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006;166:1836-41
12. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521-30
13. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002;40:794-811
14. Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm 2006;12:239-45
15. Catalan VS, Lelorier J. Predictors of Long-term Persistence on Statins in a Subsidized Clinical Population. Value Health 2000;3:417-26
16. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53
17. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72
18. Knight EL, Bohn RL, Wang PS, Glynn RJ, Mogun H, Avorn J. Predictors of uncontrolled hypertension in ambulatory patients. Hypertension 2001;38:809-14
19. Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 2004;19:357-62
20. Svensson S, Kjellgren KI, Ahlner J, Saljo R. Reasons for adherence with antihypertensive medication. Int J Cardiol 2000;76(2-3):157-63
21. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97
22. Giles TD. Rationale for combination therapy as initial treatment for hypertension. J Clin Hypertens (Greenwich) 2003;5(4 Suppl 3):4-11